SHR3680

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for SHR3680, covering 2020-05-13 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy [Phase 3]